Skip to main content Skip to footer
Nighthawk Biosciences, Inc.
  • Home
  • About
    • Management Team
    • Board of Directors
  • Scorpius Biomanufacturing
  • Investors & News
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Corporate Presentation
  • Contact

Press Releases

Investors & News

Investors & News

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Corporate Presentation
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Aug 30, 2021 7:30am EDT

Heat Biologics to Provide Corporate Update

Aug 26, 2021 8:00am EDT

Heat Biologics Unveils Skunkworx Bio, New Drug Discovery Subsidiary

Aug 23, 2021 8:00am EDT

Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory Board

Aug 19, 2021 9:00am EDT

Heat Biologics Announces New Additions to Biothreat Advisory Board

Aug 18, 2021 8:00am EDT

Heat Biologics Announces Formation of Biothreat Advisory Board

Aug 11, 2021 4:05pm EDT

Heat Biologics Provides Second Quarter 2021 Business Update

Aug 09, 2021 7:30am EDT

Heat Biologics Announces Groundbreaking for New San Antonio Facility

Jun 28, 2021 7:30am EDT

Heat Biologics Joins Russell Microcap® Index

Jun 23, 2021 7:30am EDT

Heat Biologics Announces Significant Expansion of R&D and Pre-Clinical Capabilities at Corporate Headquarters

Jun 04, 2021 9:00am EDT

Heat Biologics to Showcase Favorable Survival Data of HS-110 in Previously Treated Non-Small Cell Lung Cancer Patients at 2021 American Society of Clinical Oncology Annual Meeting

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 31
  • Next Pagearrow_forward
rss_feed News RSS
NightHawk Biosciences
  • Email Alerts
  • Contacts
  • RSS News Feed
©2024 Nighthawk Biosciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap
  • Visit us on LinkedIn
  • Visit us on Twitter
  • Visit us on YouTube
  • Visit us on Facebook

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.